Is Abbreviated MRI a Good Option?

Abbreviated Breast MRI is a low cost effecting and additional screening exam as compared to Breast MRI and that is why it is more common for detecting dense breast in women. It is regarded as the most sensitive tool for detecting breast cancer in women. 

What is 3D Mammography?

This is one of the modern methods, which helps in the analysis of dense breast cancer. It is mostly used in cases of breast cancer, where analysing the tissue is imperative for treatment. There are a lot of alternatives to this method, namely traditional mammography

Difficult Questions to Ask for Improving Breast Cancer Detection

Early detection of breast cancer is critical to survival. One in eight women will have breast cancer in their lifetime, with an early stage (American Cancer Society) survival rate of 99 percent for five years. Given these figures and the known limitations of the current detection of breast cancer,

5 Fast Facts about Breast Cancer Detection

Breast cancer is the most common cancer among women in the world, claiming the lives of hundreds of thousands of women every year and affecting countries at all levels of modernization, according to the World Health Organization.

How Can Complementary Diagnostic Tools Improve Breast Cancer Detection?

50% Women's breasts are dense. High breast density on a mammogram is known to obscure cancer, often described as seeking a polar bear in a snowstorm that can lead to false negative results–results where early cancer is not identified and breast cancer is therefore detected at a later stage. It is diagnosed with the later breast cancer, the lower chance of survival. 

Effects of having extremely dense breasts

Less fatty tissue and more non - fatty tissue have dense breasts. Therefore, if your mother has dense breasts, there is an increased likelihood that you will have dense breasts as well.Breast density can have a significant impact on the accuracy of routine detection methods, such as mammography screening. 

Breast cancer biomarkers

Due to the discovery of specific prognostic and predictive bio-markers that allow the application of more individualized therapies to different molecular subgroups, breast cancer treatment has experienced several changes over the past decades.